Skye Bioscience (SKYE) Enterprise Value (2015 - 2026)
Skye Bioscience's Enterprise Value came in at $14.27 million for Q2 2026, down 87.8% from $117.19 million a year earlier but up 217.6% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Enterprise Value (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Skye Bioscience reported Enterprise Value of -$63.89 million; for FY2025, it came in at -$703,619.
- Going back by year, Enterprise Value was $19.24 million in FY2024 (+8.1%), $17.8 million in FY2023 (+133.0%), $7.64 million in FY2022 (-51.6%) and $15.77 million in FY2021 (+133.3%).
- The five-year range for quarterly Enterprise Value is -$703,619 (Q4 2025) to $355.56 million (Q1 2024).
- Year-over-year, Enterprise Value increased in four of the last seven quarters, with growth averaging 6.1%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2021 (growth of 519.6%), and the weakest in Q1 2025 (a decline of 98.9%).
- Business Quant data shows SKYE's Enterprise Value at $4.49 million (Q1 2026), -$703,619 (Q4 2025) and $120.57 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Skye Bioscience | 7.07 Mn | 7.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.27 Mn |
| Mar 31, 2026 | 4.49 Mn |
| Dec 31, 2025 | -703,619.00 |
| Sep 30, 2025 | 120.57 Mn |
| Jun 30, 2025 | 117.19 Mn |
| Mar 31, 2025 | 3.82 Mn |
| Dec 31, 2024 | 19.24 Mn |
| Sep 30, 2024 | 84.37 Mn |
| Jun 30, 2024 | 235.62 Mn |
| Mar 31, 2024 | 355.56 Mn |
| Dec 31, 2023 | 17.80 Mn |
| Sep 30, 2023 | 27.11 Mn |
| Jun 30, 2023 | 19.85 Mn |
| Mar 31, 2023 | 13.85 Mn |
| Dec 31, 2022 | 7.64 Mn |
| Sep 30, 2022 | 12.48 Mn |
| Jun 30, 2022 | 14.43 Mn |
| Mar 31, 2022 | 12.84 Mn |
| Dec 31, 2021 | 15.77 Mn |
| Sep 30, 2021 | 38.90 Mn |
API Access
Skye Bioscience Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();